RITTER PHARMACEUTICALS INC (RTTR) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 31 transactions totaling $8.6M, demonstrating a bullish sentiment with $8.4M in net insider flow. The most recent transaction on Apr 10, 2020 involved a transaction of 38,461 shares valued at $0.
No significant insider buying has been recorded for RTTR in the recent period.
No significant insider selling has been recorded for RTTR in the recent period.
Based on recent SEC filings, insider sentiment for RTTR is bullish with an Insider Alignment Score of 99/100 and a net flow of $8.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at RITTER PHARMACEUTICALS INC (RTTR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading RTTR stock, having executed 31 transactions in the past 90 days. The most active insider is Noah Doyle (Executive), who has made 6 transactions totaling $4.2M.
Get notified when executives and directors at RTTR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 10, 2020 | W. Foehr Matthew | Executive | Award | 38,461 | $N/A | $0 | |
| Mar 12, 2020 | Doyle Noah | Executive | Sale | 500,000 | $0.22 | $110.0K | |
| Mar 4, 2020 | J. Ritter Andrew | Executive | Sale | 18,750 | $0.38 | $7.1K | |
| Mar 4, 2020 | E. Ritter Ira | Executive | Sale | 18,750 | $0.38 | $7.1K | |
| Feb 25, 2020 | Doyle Noah | Executive | Option Exercise | 500,000 | $0.15 | $75.0K | |
| Jan 21, 2020 | W. Foehr Matthew | Executive | Conversion | 76,923 | $N/A | $0 | |
| Aug 17, 2018 | W. Foehr Matthew | Executive | Purchase | 19,751 | $2.04 | $40.3K | |
| Aug 17, 2018 | W. Foehr Matthew | Executive | Purchase | 19,751 | $2.04 | $40.3K | |
| Oct 3, 2017 | Partners, L.p. Javelin Venture | Executive | Purchase | 5,000,000 | $N/A | $0 | |
| Oct 3, 2017 | Doyle Noah | Executive | Purchase | 5,000,000 | $N/A | $0 | |
| Oct 3, 2017 | E. Ritter Ira | Executive | Purchase | 187,500 | $N/A | $0 | |
| Oct 3, 2017 | J. Ritter Andrew | Executive | Purchase | 187,500 | $N/A | $0 | |
| May 18, 2017 | W. Foehr Matthew | Executive | Purchase | 18,000 | $0.62 | $11.2K | |
| May 11, 2017 | D. Step Michael | Executive | Purchase | 13,000 | $0.62 | $8.1K | |
| Feb 27, 2017 | D. Step Michael | Executive | Purchase | 8,000 | $2.65 | $21.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 18 | $8.5M | 97.7% |
Sale(S) | 3 | $124.3K | 1.4% |
Exercise(M) | 1 | $75.0K | 0.9% |
Award(A) | 1 | $0 | 0.0% |
Conversion(C) | 8 | $0 | 0.0% |
Insiders at RITTER PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 9 insiders making 31 transactions totaling $8.5M in purchases versus $124.3K in sales, the net buying activity of $8.4M signals strong executive confidence. Noah Doyle (Executive) leads the buying activity with $4.2M in transactions across all time.